Page 107 - GTM-3-4

Global Translational Medicine Prediction of in-stent restenosis

of the institutional and/or national Research Ethics doi: 10.3238/arztebl.m2021.0254
Committee and the 1964 Helsinki Declaration and its 10. Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of
subsequent changes or comparable standards of ethics. in-stent restenosis. J Am Coll Cardiol. 2014;63(24):2659-2673.
Informed voluntary consent was obtained from each of the doi: 10.1016/j.jacc.2014.02.545
participants in the study.
11. Hamon M, Bauters C, McFadden EP, et al. Restenosis after
Consent for publication coronary angioplasty. Eur Heart J. 1995;16(Suppl I):33-48.
Written informed consent for the publication of any doi: 10.1093/eurheartj/16.suppl_i.33
associated data was obtained from each participant in the 12. Jukema JW, Verschuren JJ, Ahmed TA, Quax PH. Restenosis
study. after PCI. Part 1: pathophysiology and risk factors. Nat Rev
Cardiol. 2011;9:53-62.
Availability of data
doi: 10.1038/nrcardio.2011.132
The datasets generated and/or analyzed during the current 13. Buccheri D, Cimino G. Drug-eluting stent restenosis
study are available from the corresponding author on treatment: An “old” stent, a “new” balloon or a “newer”
reasonable request. scaffold? J Thorac Dis. 2016;8(12):3478-3483.

References doi: 10.21037/jtd.2016.12.21
1. GBD 2017 Causes of Death Collaborators. Global, regional, 14. Gori T. Restenosis after coronary stent implantation: Cellular
and national age-sex-specific mortality for 282 causes mechanisms and potential of endothelial progenitor cells
of death in 195 countries and territories, 1980-2017: (a short guide for the interventional cardiologist). Cells.
A systematic analysis for the Global Burden of Disease Study 2022;11(13):2094.
2017. Lancet. 2018;392(10159):1736-1788. doi: 10.3390/cells11132094
doi: 10.1016/S0140-6736(18)32203-7 15. Neubauer K, Zieger B. Endothelial cells and coagulation.
2. Townsend N, Kazakiewicz D, Wright FL, et al. Epidemiology Cell Tissue Res. 2022;387:391-398.
of cardiovascular disease in Europe. Nat Rev Cardiol. doi: 10.1007/s00441-021-03471-2
2022;19(2):133-143.
16. Timmis A, Townsend N, Gale C, et al. European society of
doi: 10.1038/s41569-021-00607-3 cardiology: Cardiovascular disease statistics 2017. Eur Heart
3. Russian Statistical Yearbook 2021. Russia: Federal State J. 2018;39:508-579.
Statistics Service; 2021. p. 692. doi: 10.1093/eurheartj/ehx628
4. Karpin AD, Starvinsky VV, Shakhzadova AO, Lisichnikova 17. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents
IV. Malignant Neoplasms in Russia in 2021 (Morbidity and versus standard stents in patients with stenosis in a native
Mortality). Russia: Federal State Statistics Service; 2022. coronary artery. N Engl J Med. 2003;349:1315-1323.
p. 233.
doi: 10.1056/NEJMoa035071
5. The Demographic Yearbook of Russia 2021. Russia: Federal
State Statistics Service; 2021. p. 256. 18. Shumakov DV, Shekhyan GG, Zybin DI, Yalymov AA,
Vedenikin TY, Popov MA. In-stent restenosis: Symptoms,
6. Alekyan BG, Grigoryan AM, Staferov AV, Karapetyan NG. hemodynamic signs, pathogenesis and treatment. Russ
X-ray endovascular diagnostics and treatment of heart and Cardiol Bull. 2021;16(1):20-27.
vascular diseases in the Russian Federation. Endovasc Surg J.
2021;8:233. doi: 10.17116/cardiobulletin20211601120
7. Kalinina AM, Ipatov PV, Kushunina DV, et al. Results of 19. Fröbert O, Lagerqvist B, Carlsson J, Lindbäck J, Stenestrand U,
circulatory disease detection during prophylactic medical James SK. Differences in restenosis rate with different
examination of the adult population: The first two years’ drug-eluting stents in patients with and without diabetes
experience. Terapevticheskii Arkhiv. 2016;88(1):46-52. mellitus: A report from the SCAAR (Swedish Angiography
and Angioplasty Registry). J Am Coll Cardiol. 2009;53(18):
8. Stone G, Maehara A, Lansky A, et al. A prospective 1660-1667.
natural - history study of coronary atherosclerosis. N Engl J
Med. 2011;364(3):226-235. doi: 10.1016/j.jacc.2009.01.054
20. MacRury SM, Lowe GD. Blood rheology in diabetes mellitus.
doi: 10.1056/NEJMoa1002358
Diabet Med. 1990;7(4):285-291.
9. Ullrich H, Olschewski M, Münzel T, Gori T. Coronary
in-stent restenosis: Predictors and treatment. Dtsch Arztebl doi: 10.1111/j.1464-5491.1990.tb01391.x37
Int. 2021;118(38):637-644. 21. Ostermann H, van de Loo J. Factors of the hemostatic

Volume 3 Issue 4 (2024) 9 doi: 10.36922/gtm.4957